Cortagen is a synthetic tetrapeptide — Ala-Glu-Asp-Pro (AEDP) — developed by Professor Vladimir Khavinson as the peripheral nervous system bioregulator. It is classified as a Cytogen: the synthetic short peptide form, administered by subcutaneous injection. The name reflects its origin in cortical nervous system tissue research.
Most longevity protocols focus on brain aging. The peripheral nervous system — the 100,000 kilometers of nerves running through your body outside the brain and spinal cord — is rarely the focus. Yet peripheral neuropathy is one of the most common complications of aging: declining nerve conduction velocity, loss of sensory acuity, reduced proprioception, impaired autonomic function. Cortagen is designed to target this neglected system.
Cortagen is used primarily in combination with Pinealon (the CNS bioregulator) in cognitive and neurological longevity protocols — addressing the full nervous system from two angles simultaneously: Pinealon for central neuroprotection, Cortagen for peripheral nerve health.
How it works
Peripheral Nerve Chromatin Interaction
Cortagen follows the Khavinson epigenetic model: a short peptide sequence that can penetrate peripheral nerve cell nuclei and interact with chromatin, regulating gene expression in peripheral nervous system tissue. The AEDP sequence is derived from research on cortical/peripheral nerve tissue and is proposed to be preferentially taken up by peripheral nerve cells.
Neurotrophic Factor Modulation
Cell and animal studies show Cortagen modulates expression of nerve growth factor (NGF) and other neurotrophic signaling molecules that decline with age and are essential for nerve maintenance and repair. This neurotrophic support addresses one of the root causes of peripheral nerve degeneration.
Schwann Cell and Myelin Support
Schwann cells are the glial cells of the peripheral nervous system — they form the myelin sheaths that insulate nerve fibers and govern conduction velocity. Research suggests Cortagen influences Schwann cell gene expression, potentially supporting myelin maintenance and peripheral nerve conduction speed in aged tissue.
What the research shows
NOTE — PRIMARILY KHAVINSON GROUP DATA · SMALL CLINICAL STUDIES · NO WESTERN RCTS
STUDYBulletin of Experimental Biology and Medicine · 2004
Cortagen in Peripheral Neuropathy — Nerve Conduction and Sensory Outcomes
Khavinson VK et al.
Patients with peripheral neuropathy (diabetic and age-related) receiving Cortagen showed improved nerve conduction velocity and reduced neuropathic symptoms vs. controls at 3-month follow-up. Improvements in vibration sensitivity and proprioception were observed in the treated group.
AEDP Tetrapeptide Preserves Peripheral Nerve Function in Aged Animals
Khavinson VK et al.
Aged rats treated with Cortagen showed preserved peripheral nerve conduction velocity, reduced axonal degeneration markers, and maintained Schwann cell integrity compared to untreated aged controls. Effects were most pronounced in animals with the most severe baseline nerve aging.
STUDYSaint Petersburg Institute of Bioregulation and Gerontology Publication · 2010
Additive Neuroprotection with Cortagen + Pinealon Combination
Khavinson VK et al.
Combined Cortagen + Pinealon administration in aged animals showed superior neuroprotective effects compared to either compound alone — consistent with complementary mechanisms at the peripheral and central nervous system levels. Authors proposed this as the mechanistic rationale for the CNS + PNS combination protocol.
Cortagen has moderate biohacker interest, primarily among people with neurological longevity as a priority goal. It is almost always used alongside Pinealon — the combination of CNS (Pinealon) + PNS (Cortagen) represents the “complete neurological longevity stack” in the bioregulator framework.
Anecdotal reports focus on improved sensory acuity, reduced peripheral numbness or tingling, and better nerve-related symptoms in people with early neuropathy. Given the overlap with placebo effect in subjective neurological symptoms, these reports require cautious interpretation. The animal and cell data is more compelling than the anecdotal signal.
WHAT THE RESEARCH SHOWS
✓KNOWN
✓Cortagen (AEDP) is the peripheral nervous system Cytogen — distinct from Pinealon's CNS focus
✓Cell and animal studies show neuroprotective effects, Schwann cell support, and myelin maintenance
✓Small human clinical data suggests nerve conduction velocity improvement in peripheral neuropathy patients
✓Combination with Pinealon shows additive neuroprotective effects in animal models
✓Well-tolerated in available clinical data with no serious adverse events reported
?UNCERTAIN
?Whether Cortagen produces measurable benefit in people without existing peripheral neuropathy
?Optimal dosing protocol — clinical studies used varied protocols not standardized for biohacker use
?Whether the PNS specificity of AEDP is as organ-selective as the bioregulator theory predicts
?Long-term safety profile beyond Russian clinical observation data
?Independent Western-standard RCT replication of neuroprotective effects
RECONSTITUTION CALCULATOR
EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN
AI COACH PREVIEW
I'm 58 with some early peripheral neuropathy (mild tingling in feet, slightly reduced sensation). I'm already doing Epithalon and Pinealon annually. Should I add Cortagen and how would I structure it?
Yes — Cortagen makes sense here and your stack is already well-positioned for this addition. You have the CNS covered with Pinealon; Cortagen addresses the peripheral side specifically. The standard protocol: 20 mcg/day SC for 10 days, 1–2 courses per year. Given you already have peripheral symptoms, I'd lean toward two courses annually (spring and autumn) alongside your Pinealon run rather than one. The animal combination data shows additive effects — running them concurrently is reasonable. What's worth knowing: at your symptom stage, the goal is stabilization and slowing progression rather than expecting dramatic reversal. Early intervention matters more than aggressive dosing. Continue monitoring sensation objectively if you can — nerve conduction velocity testing gives you real data points to track against.
CONTINUE IN THE APP
Open PepperLedger to ask the Coach about Cortagen and neurological bioregulator stacking →
Free to join. The Coach understands the full Khavinson bioregulator system and can help you design a complete nervous system protocol.
Free to join · No credit card · 23-day Pro trial included